IL6 and COVID-19: In COVID-19 patients, IL-6 levels are significantly elevated, so serum IL-6 was used as a biomarker of COVID-19 severity and to decide on the administration of immunosuppressive treatment for the famous cytokine storm, based on experience in rheumatological and autoimmune diseases.